X4 Pharmaceuticals, Inc. (XFOR)
3.84
-0.14
(-3.52%)
USD |
NASDAQ |
Dec 08, 16:00
3.845
0.00 (0.00%)
After-Hours: 20:00
X4 Pharmaceuticals EPS Diluted (Quarterly): -0.689 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Altimmune, Inc. | -0.2126 |
| Adverum Biotechnologies, Inc. | -2.029 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Quantum-Si, Inc. | -0.1708 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.82M |
| Revenue (Quarterly) | 1.765M |
| Total Expenses (Quarterly) | 31.58M |
| Enterprise Value | 290.70M |
| Gross Profit Margin (Quarterly) | 78.81% |
| Profit Margin (Quarterly) | -1.69K% |
| Earnings Yield | -260.6% |
| Normalized Earnings Yield | -288.37 |